Iowa Biotech Association
Tweet
  • About
    • Board of Directors
    • Staff Members
    • Legislative Priorities
    • Careers at IowaBio
  • Industry News
    • COVID-19 Updates
    • Monthly Newsletters
    • Session Bill Trackers
    • IowaBio News
  • Membership
    • Member Login/Join
    • Membership Categories & Dues
    • Membership Benefits
    • Member of the Month
  • Resources
    • 2021 IowaBio Legislative Update Calls
    • 2021 Iowa Biotech Showcase & Conference
    • IowaBio Event Recaps
    • Global Events Calendar
    • STEM Activities
    • Life Science Asset Databases
    • Biobased Chemicals Report
    • Legal
    • Battelle Reports
  • Partners
    • Fisher Scientific
    • VWR
    • Wynn O. Jones
    • Office Depot
    • Chubb Insurance
    • UPS
    • BREX - Corporate Credit Card for Life Sciences
    • BIO
  • Contact
    • Contact Us
  • Member Login/Join
  • Membership Categories & Dues
  • Membership Benefits
  • Member of the Month
Home « Members Directory

Members Directory

MedCara Pharmaceuticals, LLC

Back to Search Results

Profile:

Full Name: MedCara Pharmaceuticals, LLC
http://www.medcara.com/
Tom Swegle

Addresses:

Business
126 N. Main
Conrad, IA 50621
Ph: 515-557-6758
Fax: 641-366-3442

Details:

  • Healthcare & Pharma

Description:

<p>MedCara Pharmaceuticals, an early-stage pharmaceutical company focused in the dermatological market, was organized as an LLC in the State of Iowa in 2006. Its flagship product is a topical treatment for resistant nongenital cutaneous warts called WartPEEL. The wart therapy indication represents an unprecedented opportunity because WartPEEL would be the first FDA approved topical prescription drug available for the treatment of resistant warts. MedCara has combined two proven drug actives and developed a novel topical formulation of the drug for treating resistant warts. The Company has been self-funded since inception and is now pursuing financing to fund the execution of its on-going clinical development programs. The active ingredients in WartPEEL have been approved by the FDA, and thus from a regulatory perspective, MedCara's product is a reformulation, combination drug. For more information, please visit <a href="http://www.medcara.com" target="_blank">www.medcara.com</a>.</p>

Membership Level:

Entrepreneur

Locate Member:

View Map

© 2021 Iowa Biotechnology Association. All Rights Reserved.
Iowa Biotechnology Association
500 E Court Ave., Suite 112, Des Moines, IA 50309-2057
Ph 515-327-9156  |  Fax 515-327-1407  |  Email Us
Home  |  Privacy  |  Sitemap  |  Feedback
Powered by SiteViz